long covid

Full title: Effects of l-Arginine Plus Vitamin C Supplementation on Physical Performance, Endothelial Function, and Persistent Fatigue in Adults with Long COVID: A Single-Blind Randomized Controlled Trial Abstract Long COVID, a condition characterized by symptom and/or sign persistence...

Full title: Effects of a concurrent training, respiratory muscle exercise and self-management recommendations on recovery from post-COVID-19 conditions: the RECOVE trial Abstract The aim of this study was to determine the effectiveness of physical exercise, respiratory muscle training and the...

INTRODUCTION “Long COVID” is defined as symptoms that persist 12 weeks beyond the acute phase of the coronavirus-2019 (COVID-19) infection and is estimated to affect 3.0% to 11.7% of the UK population. Symptoms include headache, myalgia, fatigue, and loss of taste and smell.1 Parosmia can...

Abstract Background The COVID-19 pandemic has given rise to an increasing number of patients with ‘long COVID’. Long COVID is the persistence of symptoms for weeks or months after an infection by SARS-CoV-2. It often impacts on the professional life of affected people. Aims The aim of this...

Full title: Prevalence and severity of symptoms 3 months after infection with SARS-CoV-2 compared to test-negative and population controls in the Netherlands ABSTRACT Background This prospective study assesses symptoms three months after SARS-CoV-2-infection compared to test-negative and...

very long piece (I've only skimmed through it). https://newrepublic.com/article/168965/might-long-covid-wrong eta: (from Esther12) Archive link that avoids giving them clicks: https://archive.vn/L471V

Abstract Background Neurological symptoms associated with coronavirus disease 2019 (COVID-19), such as fatigue and smell/taste changes, persist beyond infection. However, little is known of brain physiology in the post-COVID-19 timeframe. Purpose To determine whether adults who experienced...

Abstract Background Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is characterized by persistent physical and mental fatigue. The post-COVID-19 condition patients refer physical fatigue and cognitive impairment sequelae. Given the similarity between both conditions, could it be...

Full title: Fatigue, post-exertional malaise and orthostatic intolerance: a map of Cochrane evidence relevant to rehabilitation for people with post COVID-19 condition INTRODUCTION: Rehabilitation focuses on impairments, activity limitations and participation restrictions being informed by the...

Groundbreaking research into ME/CFS a pandemic ‘silver lining’ https://healthydebate.ca/2022/12/topic/research-mecfs-pandemic-silver-lining/

Full title: Cochrane “evidence relevant to” rehabilitation of people with post COVID-19 condition. What it is and how it has been mapped to inform the development of the World Health Organization recommendations Cochrane Rehabilitation developed a series of actions to provide the global...

New CDC Foundation Program Focuses on Creating Partnerships to Address Chronic Conditions Caused by Infections, Including Long COVID...

Abstract Persistent symptoms after acute COVID-19 infection, termed post-COVID-19 fatigue, occur in 44–70% of patients. Characterizing fatigue in this population is vital to determine the etiology of post-COVID-19 fatigue symptoms and to assess the effectiveness of potential interventions...

Full title: Association of Initial SARS-CoV-2 Test Positivity With Patient-Reported Well-being 3 Months After a Symptomatic Illness Open access: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2799116 Question How do patient-reported physical, mental, and social well-being compare...

Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes Hao Zhang, Chengxi Zang, Zhenxing Xu, Yongkang Zhang, Jie Xu, Jiang Bian, Dmitry Morozyuk, Dhruv Khullar, Yiye Zhang, Anna S. Nordvig, Edward J. Schenck, Elizabeth A. Shenkman, Russell L. Rothman, Jason P. Block, Kristin...

Persistent alveolar type 2 dysfunction and lung structural derangement in post-acute COVID-19 Andre Figueiredo Rendeiro, Hiranmayi Ravichandran, Junbum Kim, Alain Borczuk, Olivier Elemento, Robert Edward Schwartz SARS-CoV-2 infection can manifest as a wide range of respiratory and systemic...

Abstract Background To update and internally validate a model to predict children and young people (CYP) most likely to experience long COVID (i.e. at least one impairing symptom) 3 months after SARS-CoV-2 PCR testing and to determine whether the impact of predictors differed by SARS-CoV-2...

https://thorax.bmj.com/content/77/Suppl_1/A2.1.abstract Abstract Introduction and Objectives Neutrophils are increasingly recognised for a role in acute COVID19, contributing to hyperinflammatory responses, immunothrombosis and tissue damage. However, less is known about the cellular changes...

Financial Times article: Blood clot drug totally ineffective as post-Covid treatment, research finds Results from UK-wide trials on anticoagulant Apixaban set to change protocols around the world A drug to reduce blood clots, widely prescribed to Covid-19 patients after discharge from hospital...

Abstract Background Stigma can be experienced as perceived or actual disqualification from social and institutional acceptance on the basis of one or more physical, health-related, behavioural, or other attributes deemed to be undesirable. Long COVID is a predominantly multisystem condition...